This is the first tender exercise in a new three-month quota period, when there are 8.2% more COEs. Read more at straitstimes ...
Vor Biopharma Inc., a biotechnology firm specializing in biological products, has announced a significant adjustment to the exercise prices of certain stock options. On Monday, the company's board ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback